Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Feb-24 7:34 PM View:  | Forman Mark S Chief Medical Officer | Passage Bio, Inc. (PASG) | 13-Feb-24 | Option Sale | 1,638 | $0.97 | $1,588.86 | (3%) 50.27K to 48.63K | |
| 13-Feb-24 7:36 PM View: | Borthwick Kathleen SVP, Interim CFO | Passage Bio, Inc. (PASG) | 13-Feb-24 | Option Sale | 1,470 | $0.97 | $1,425.90 | (5%) 29.94K to 28.47K | |
| 13-Feb-24 7:34 PM View: | Forman Mark S Chief Medical Officer | Passage Bio, Inc. (PASG) | 10-Feb-24 | Option Exercise | 5,000 | -- | -- | 11% 45.27K to 50.27K | |
| 13-Feb-24 7:36 PM View: | Borthwick Kathleen SVP, Interim CFO | Passage Bio, Inc. (PASG) | 10-Feb-24 | Option Exercise | 4,000 | -- | -- | 15% 25.94K to 29.94K | |
| 03-Jan-24 4:21 PM View: | Forman Mark S Chief Medical Officer | Passage Bio, Inc. (PASG) | 02-Jan-24 | Option Sale | 15,813 | $0.91 | $14,389.80 | (26%) 61.08K to 45.27K | |
| 03-Jan-24 4:20 PM View: | Borthwick Kathleen SVP, Interim CFO | Passage Bio, Inc. (PASG) | 02-Jan-24 | Option Sale | 10,672 | $0.91 | $9,711.52 | (29%) 36.61K to 25.94K | |
| 03-Jan-24 4:19 PM View: | Cale Edgar B. GC & Corporate Secretary | Passage Bio, Inc. (PASG) | 02-Jan-24 | Option Sale | 15,813 | $0.91 | $14,389.80 | (26%) 61.81K to 45.99K | |
| 03-Jan-24 4:21 PM View: | Forman Mark S Chief Medical Officer | Passage Bio, Inc. (PASG) | 31-Dec-23 | Option Exercise | 50,000 | -- | -- | 451% 11.08K to 61.08K | |
| 03-Jan-24 4:20 PM View: | Borthwick Kathleen SVP, Interim CFO | Passage Bio, Inc. (PASG) | 31-Dec-23 | Option Exercise | 30,000 | -- | -- | 454% 6.61K to 36.61K | |
| 03-Jan-24 4:19 PM View: | Cale Edgar B. GC & Corporate Secretary | Passage Bio, Inc. (PASG) | 31-Dec-23 | Option Exercise | 50,000 | -- | -- | 423% 11.81K to 61.81K | |
| 01-Aug-23 4:36 PM View: | King Simona Chief Financial Officer | Passage Bio, Inc. (PASG) | 28-Jul-23 | Option Exercise | 31,250 | -- | -- | 745% 4.2K to 35.45K | |
| 01-Aug-23 4:36 PM View: | King Simona Chief Financial Officer | Passage Bio, Inc. (PASG) | 28-Jul-23 | Option Sale | 11,453 | $0.88 | $10,078.60 | (32%) 35.45K to 23.99K | |
| 29-Jun-23 4:42 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 28-Jun-23 | Purchase | 575,195 | $0.84 | $483,164.00 | 8% 7.46M to 8.03M | |
| 29-Jun-23 4:42 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 27-Jun-23 | Private Purchase | 617,382 | $0.84 | $518,601.00 | 9% 6.84M to 7.46M | |
| 20-Jun-23 4:10 PM View: | Fotopoulos Alexandros Chief Technical Officer | Passage Bio, Inc. (PASG) | 16-Jun-23 | Option Sale | 4,052 | $0.93 | $3,778.49 | (12%) 32.74K to 28.69K | |
| 20-Jun-23 4:10 PM View: | Fotopoulos Alexandros Chief Technical Officer | Passage Bio, Inc. (PASG) | 15-Jun-23 | Option Exercise | 12,500 | -- | -- | 62% 20.25K to 32.74K | |
| 20-Apr-23 4:28 PM View: | King Simona Chief Financial Officer | Passage Bio, Inc. (PASG) | 18-Apr-23 | Option Sale | 2,053 | $1.05 | $2,155.65 | (50%) 4.11K to 2.05K | |
| 02-Dec-22 5:14 PM View: | Kapadia Sandip Director | Passage Bio, Inc. (PASG) | 01-Dec-22 | Sale (Planned) | 5,000 | $1.19 | $5,964.50 | (100%) 5.0K to 0 | |
| 25-Nov-22 4:15 PM View: | Fotopoulos Alexandros Chief Technical Officer | Passage Bio, Inc. (PASG) | 22-Nov-22 | Option Sale | 3,720 | $1.33 | $4,947.60 | (16%) 23.96K to 20.25K | |
| 25-Nov-22 4:15 PM View: | Fotopoulos Alexandros Chief Technical Officer | Passage Bio, Inc. (PASG) | 22-Nov-22 | Option Exercise | 12,500 | -- | -- | 109% 11.46K to 23.96K | |
| 18-Nov-22 5:01 PM View: | Toernsen Monika Maria Chief Commercial Officer | Passage Bio, Inc. (PASG) | 19-Sep-22 | Option Sale | 1,681 | $1.51 | $2,539.15 | (34%) 5.0K to 3.32K | |
| 18-Nov-22 5:01 PM View: | Toernsen Monika Maria Chief Commercial Officer | Passage Bio, Inc. (PASG) | 15-Sep-22 | Option Exercise | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 05-May-22 5:23 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 04-May-22 | Purchase | 303,500 | $1.94 | $588,790.00 | 5% 6.54M to 6.84M | |
| 05-May-22 5:23 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 03-May-22 | Private Purchase | 221,500 | $1.93 | $427,495.00 | 4% 6.32M to 6.54M | |
| 23-Mar-22 4:43 PM View: | Goldsmith Bruce A CEO and President Director | Passage Bio, Inc. (PASG) | 21-Mar-22 | Private Purchase | 10,000 | $3.15 | $31,500.00 | 167% 5.98K to 15.98K | |
| 24-Jan-22 4:44 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 20-Jan-22 | Private Purchase | 369,100 | $5.42 | $2,000,520.00 | 6% 6.27M to 6.63M | |
| 20-Jan-22 6:03 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 19-Jan-22 | Purchase | 43,300 | $5.11 | $221,263.00 | < 1% 6.22M to 6.27M | |
| 20-Jan-22 6:03 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 18-Jan-22 | Purchase | 114,700 | $5.46 | $626,262.00 | 2% 6.11M to 6.22M | |
| 20-Jan-22 6:03 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 14-Jan-22 | Private Purchase | 10,300 | $5.60 | $57,680.00 | < 1% 6.1M to 6.11M | |
| 13-Jan-22 7:37 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 13-Jan-22 | Purchase | 41,800 | $5.52 | $230,736.00 | < 1% 6.06M to 6.1M | |
| 13-Jan-22 7:37 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 12-Jan-22 | Purchase | 100,000 | $5.65 | $565,000.00 | 2% 5.96M to 6.06M | |
| 13-Jan-22 7:37 PM View: | Orbimed Advisors LLC 10% Owner | Passage Bio, Inc. (PASG) | 11-Jan-22 | Private Purchase | 8,200 | $5.53 | $45,346.00 | < 1% 5.95M to 5.96M | |
| 10-Dec-21 5:30 PM View: | Quigley Jill M. Chief Operating Officer | Passage Bio, Inc. (PASG) | 08-Dec-21 | Option Exercise | 71,975 | $0.23 | $16,554.20 | 24% 300.39K to 372.36K | |
| 21-May-21 6:09 PM View: | Morris Richard Steven Chief Financial Officer | Passage Bio, Inc. (PASG) | 21-May-21 | Market Purchase | 2,171 | $13.82 | $29,999.50 | 66% 3.28K to 5.45K | |
| 21-May-21 6:05 PM View: | Goldsmith Bruce A CEO and President Director | Passage Bio, Inc. (PASG) | 21-May-21 | Market Purchase | 2,000 | $13.11 | $26,230.00 | 50% 3.98K to 5.98K | |
| 17-Mar-21 9:12 PM View: | Romano Gary Chief Medical Officer | Passage Bio, Inc. (PASG) | 15-Mar-21 | Market Option Sale (Planned) | 10,000 | $21.10 | $211,013.00 | (100%) 10.0K to 0 | |
| 17-Mar-21 9:12 PM View: | Romano Gary Chief Medical Officer | Passage Bio, Inc. (PASG) | 15-Mar-21 | Option Exercise | 10,000 | $8.07 | $80,700.00 | 100% 0 to 10.0K | |
| 22-Jan-21 5:54 PM View: | Quigley Jill M. Chief Operating Officer | Passage Bio, Inc. (PASG) | 20-Jan-21 | Market Sale (Planned) | 1,300 | $30.01 | $39,011.10 | (< 1%) 297.58K to 296.28K | 24% |
| 15-Jan-21 8:29 PM View: | Quigley Jill M. Chief Operating Officer | Passage Bio, Inc. (PASG) | 14-Jan-21 | Market Sale (Planned) | 16,298 | $30.10 | $490,570.00 | 6% 281.29K to 297.58K | (< 1%) |
| 25-Mar-20 8:26 PM View: | Countouriotis Athena Director | Passage Bio, Inc. (PASG) | 24-Mar-20 | Purchase | 10,000 | $14.98 | $149,750.00 | 112% 8.9K to 18.9K | |
| 03-Mar-20 6:44 PM View: | Morris Richard Steven Chief Financial Officer | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 400 | $18.00 | $7,200.00 | 100% 0 to 0.4K | |
| 03-Mar-20 6:43 PM View: | Kapadia Sandip Director | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 5,000 | $18.00 | $90,000.00 | 100% 0 to 5.0K | |
| 03-Mar-20 6:51 PM View: | Yamada Tadataka Director | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 6,500 | $18.00 | $117,000.00 | 1% 649.65K to 656.15K | |
| 03-Mar-20 6:54 PM View: | Heron Patrick J Director 10% Owner | Passage Bio, Inc. (PASG) | 03-Mar-20 | Conversion Duplicate | 4,459,220 | -- | -- | 100% 0 to 4.46M | |
| 03-Mar-20 6:57 PM View: | Woiwode Thomas Director 10% Owner | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 225,000 | $18.00 | $4,050,000.00 | 5% 4.73M to 4.96M | |
| 03-Mar-20 6:59 PM View: | Frazier Life Sciences Ix, L... 10% Owner | Passage Bio, Inc. (PASG) | 03-Mar-20 | Conversion | 4,459,220 | -- | -- | 100% 0 to 4.46M | |
| 03-Mar-20 6:40 PM View: | Goldsmith Bruce A CEO and President Director | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 1,100 | $18.00 | $19,800.00 | 100% 0 to 1.1K | |
| 03-Mar-20 7:03 PM View: | Versant Venture Capital Vi,... 10% Owner | Passage Bio, Inc. (PASG) | 03-Mar-20 | Conversion | 708,352 | -- | -- | 18% 4.03M to 4.73M | |
| 03-Mar-20 6:35 PM View: | Cale Edgar B. GC and Corporate Secretary | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 2,000 | $18.00 | $36,000.00 | 100% 0 to 2.0K | |
| 03-Mar-20 6:37 PM View: | Countouriotis Athena Director | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 8,900 | $18.00 | $160,200.00 | 100% 0 to 8.9K |
